Net product revenue — Revenue
Eli Lilly Net product revenue — Revenue increased by 0.8% to $18.45B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.1%, from $11.60B to $18.45B. Over 4 years (FY 2021 to FY 2025), Net product revenue — Revenue shows an upward trend with a 23.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market adoption of the company's drug portfolio and successful commercial execution, while a decrease may signal patent expirations, increased competition, or supply chain constraints.
Detailed definition
This metric represents the total gross sales of pharmaceutical products generated by the company after accounting for re...
Peer comparison
This is a standard top-line revenue metric comparable to 'Net Sales' or 'Product Revenue' reported by other major pharmaceutical companies.
lly_segment_product_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.07B | $6.19B | $7.38B | $7.13B | $5.87B | $6.12B | $6.34B | $6.24B | $6.98B | $7.31B | $8.29B | $7.80B | $10.35B | $10.57B | $12.03B | $11.60B | $14.73B | $16.33B | $18.30B | $18.45B |
| QoQ Change | — | +2.0% | +19.2% | -3.3% | -17.7% | +4.2% | +3.6% | -1.6% | +11.9% | +4.7% | +13.5% | -6.0% | +32.8% | +2.1% | +13.7% | -3.5% | +26.9% | +10.9% | +12.1% | +0.8% |
| YoY Change | — | — | — | — | -3.3% | -1.1% | -14.1% | -12.5% | +18.9% | +19.4% | +30.8% | +25.0% | +48.4% | +44.7% | +45.1% | +48.8% | +42.2% | +54.5% | +52.2% | +59.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's net product revenue — revenue?
- Eli Lilly (LLY) reported net product revenue — revenue of $18.45B in Q1 2026.
- How has Eli Lilly's net product revenue — revenue changed year-over-year?
- Eli Lilly's net product revenue — revenue increased by 59.1% year-over-year, from $11.60B to $18.45B.
- What is the long-term trend for Eli Lilly's net product revenue — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's net product revenue — revenue has grown at a 23.8% compound annual growth rate (CAGR), from $25.96B to $60.96B.
- What does net product revenue — revenue mean?
- The total amount of money earned from selling pharmaceutical products after accounting for standard sales adjustments.